- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Private imaging facilitiesgrew at hospitals' expense
Use of noninvasive diagnostic imaging at private imaging facilities between 1996 and 2006 skyrocketed while hospitals' share of the imaging market fell, according to a Thomas Jefferson University study.
Use of noninvasive diagnostic imaging at private imaging facilities between 1996 and 2006 skyrocketed while hospitals' share of the imaging market fell, according to a Thomas Jefferson University study. Findings suggest hospitals failed to adjust to a booming imaging market. Dr. David C. Levin and colleagues examined nationwide Medicare Part B databases from 1996 to 2006 comparing noninvasive diagnostic imaging codes with place-of-service codes. They found NDI utilization rates per 1000 patients increased at all four places of service: hospital inpatient, hospital outpatient, private office, and emergency department. While hospital outpatient facilities and private offices saw increases of 25% and 63%, respectively, the rate for hospital inpatients grew only 15%. ER utilization rates were lower than in the other places, but their growth was fastest at 77% (J Am Coll Radiol 2009;6:96-99).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
